Lilly seeks to expand pain pipeline with $1B acquisition

Please subscribe to IBJ to decode this article.

tppbltnueala dnuoacietctcnwglp ieandy so a noelEr hT CnStoonmiqoaonieideTr ouL.ne elcd cn v as 1acyalaenbsnt. in yc p Il ya haos.rtd cin eooaiuFiihOrl-uob$isperS

dee y e t n ipragen oidd hiro0u2t di-tniei,nsheno1 nansy aodhs s4 rbose. olto dnSgr,aruhtairasasi-e o ve aume0tiitat dmtniavlth e yttctyt 0i nst.n esomot i eeyeCoSlt8 slxrassniayegtthhrad ta C ph ihNrieielaOan0r.apontf2d ipni,hifparbno cbd 1e nPTeed

ntf as- rC.idnptLcni p4rghine nn0 Toi-oroneeie,xr ptialtm0lSae i-tynmi e atgooeshorrte cand

e needi nocultsaeL0 ,Nneiourhccnmas usi.ennpofaro tre idecelpdl l e eneoltmMplshnsauht uefatana t paer crnaet agyteprdubife.tr mgaesaLo itnn,n a aoi urscdlpldttwkn eenv siacr sv eM ii d"edeee nesre"deieifthhope aae tanoreourred0siofsoott -mmr CctRcva eco nisualTrhco tnot,isrS ap ne hnitfoolo oit i"nddntt ienn siDm,rarin-pk iliriluefmeisai stO eonn rng"s Safi itacnfeaiiinpln aortvtvnsewdievtnctpf.t vematdhoer hmedot s dv teeI n n e4o,oboa-nleroi neyottmieg u Ta e nwgonenicn i

.m e dydaaeiic pnebnlssdtsuadtlo nc itl nmm ygnentfdaoaln-sdes lteotalc ipshoeopen.e eicntliueL dleruancosdsdda nsTyi peedx

edgl oSniehe i ien0gnhrmrl0a,etr ihiote dp s t ltrt nn 0vvisie, tysnonolywi c$le O0 gy mkodpo-fdsN.eTNf bca foaa isl eo dcnn orLr odirhaobrsn ng1loeaietros nfaoorinaCrolfhHdovo ei4r etdtahlmeSlheN

a.corehe i viaoaotuddOresdhrt e arurf f-r utgoennhtvasiovrozmSeClc oidtd d'oe hus tvh0tannrarnvlaotraeuct nnT iletolMxOJcegn rnsal ioOadeoealeelmnsynocCa,pi timkAefm b4outt yin-derniE eriaeafo rsio e0s me pee,hafhdurndot ew fp ea.ierldu,ciren oe eiyedeacnerseenr athrtuoinrlmnceocht odleri,onew eit rc dltlrgnrfddtaoclfcraofbp slede i lispei os ietr ta ,wesiWteS efni-ss b itLr pno ayecpinirnn ntiilaeeibipae renemp lfivei tecnt ,ia"r,p ittvr d.os a o dete on p mae dni"lep grnaftoot esipflhafmgybfr" ,oe aiiesvsSa"tce enos

r tl7 a e hi eL,ee dah23asy srl7iSirTrd.wy 0 snneu ea1dymp$%u.eoyaapltr

;p bns&